UB Paderborn / Katalog / Suche / in CDI

Ciclesonide, a Novel Inhaled Steroid, Does Not Affect Hypothalamic-Pituitary-Adrenal Axis Function in Patients With Moderate-to-Severe Persistent Asthma

Chest, 2005-09, Vol.128 (3), p.1104-1114

2005

Link zum Volltext

Verfügbarkeit prüfen

The Use of Modeling and Simulation to Guide Clinical Development of Olmesartan Medoxomil in Pediatric Subjects

Clinical pharmacology and therapeutics, 2012-02, Vol.91 (2), p.250-256

2012

Link zum Volltext

Verfügbarkeit prüfen

Population pharmacokinetic analysis to identify the possibility of interaction between anti-cancer agents

Indian journal of cancer, 2015-07, Vol.52 (3), p.461

2015

Link zum Volltext

Verfügbarkeit prüfen

Population Pharmacokinetics and Pharmacodynamics of Ciclesonide

Journal of clinical pharmacology, 2003-04, Vol.43 (4), p.365-378

2003

Link zum Volltext

Verfügbarkeit prüfen

Randomised, parallel-group, multicentre, multinational phase 2 study comparing edoxaban, an oral factor Xa inhibitor, with warfarin for stroke prevention in patients with atrial fibrillation

Thrombosis and haemostasis, 2010-09, Vol.104 (3), p.633

2010

Link zum Volltext

Verfügbarkeit prüfen

Effect of a very late antigen-4 receptor antagonist on allergen-induced airway responses and inflammation in asthma

Clinical and experimental allergy, 2005-08, Vol.35 (8), p.1080-1087

2005

Link zum Volltext

Verfügbarkeit prüfen

Modelling and simulation of edoxaban exposure and response relationships in patients with atrial fibrillation

Thrombosis and haemostasis, 2012-05, Vol.107 (5), p.925

2012

Link zum Volltext

Verfügbarkeit prüfen

Prospective dose prediction for FXa inhibitor otamixaban (OTAM) using PK/PD simulations accounting for non-dose proportional plasma exposure

Clinical pharmacology and therapeutics, 2005-02, Vol.77 (2), p.P40-P40

2005

Link zum Volltext

Verfügbarkeit prüfen

Development of a Predictive Pharmacokinetic Model for a Novel Cyclooxygenase-2 Inhibitor

Journal of clinical pharmacology, 2006-05, Vol.46 (5), p.537-548

2006

Link zum Volltext

Verfügbarkeit prüfen

Predictive Population Pharmacokinetic/Pharmacodynamic Model for a Novel COX-2 Inhibitor

Journal of clinical pharmacology, 2007-03, Vol.47 (3), p.358-370

2007

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics, Pharmacodynamics, and Safety of Inhaled Cyclosporin A (ADI628) after Single and Repeated Administration in Healthy Male and Female Subjects and Asthmatic Patients

Journal of clinical pharmacology, 2000-11, Vol.40 (11), p.1211-1226

2000

Link zum Volltext

Verfügbarkeit prüfen

Usability of a novel digital medicine system in adults with schizophrenia treated with sensor-embedded tablets of aripiprazole

Neuropsychiatric disease and treatment, 2016-01, Vol.12, p.2587-2594

2016

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics of Methylprednisolone and Prednisolone After Single and Multiple Oral Administration

Journal of clinical pharmacology, 1997-10, Vol.37 (10), p.916-925

1997

Link zum Volltext

Verfügbarkeit prüfen

PK/PD of inhaled corticosteroids: The risk/benefit of inhaled ciclesonide

Journal of allergy and clinical immunology, 2003-02, Vol.111 (2), p.S218-S218

2003

Link zum Volltext

Verfügbarkeit prüfen

A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Ebastine 20 mg Once Daily Given with and without Food in the Treatment of Seasonal Allergic Rhinitis

Journal of clinical pharmacology, 2002-10, Vol.42 (10), p.1097-1104

2002

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetic/pharmacodynamic evaluation of deflazacort in comparison to methylprednisolone and prednisolone

Pharmaceutical research, 1995-07, Vol.12 (7), p.1096-1100

1995

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetic-Pharmacodynamic Modeling of the Antilipolytic Effects of an Adenosine Receptor Agonist in Healthy Volunteers

Journal of clinical pharmacology, 2001-01, Vol.41 (1), p.61-69

2001

Link zum Volltext

Verfügbarkeit prüfen

Characterisation of exposure versus response of edoxaban in patients undergoing total hip replacement surgery

Thrombosis and haemostasis, 2012-11, Vol.108 (5), p.887

2012

Link zum Volltext

Verfügbarkeit prüfen

High doses of the novel inhaled steroid ciclesonide have no effect on HPA-axis function in patients with moderate-to-severe persistent asthma

Journal of allergy and clinical immunology, 2003-02, Vol.111 (2), p.S216-S216

2003

Link zum Volltext

Verfügbarkeit prüfen

Ciclesonide, a novel inhaled steroid, has no effect on hypothalamic-pituitary-adrenal (HPA)-axis function in mild-to-moderate asthmatics

Journal of allergy and clinical immunology, 2003-02, Vol.111 (2), p.S218-S218

2003

Link zum Volltext

Verfügbarkeit prüfen

Critical period for a teratogenic VLA-4 antagonist: Developmental effects and comparison of embryo drug concentrations of teratogenic and non-teratogenic VLA-4 antagonists

Birth defects research. Part B. Developmental and reproductive toxicology, 2004-04, Vol.71 (2), p.69-79

2004

Link zum Volltext

Verfügbarkeit prüfen

Effect of age and gender on the pharmacokinetics of ebastine after single and repeated dosing in healthy subjects

International journal of clinical pharmacology and therapeutics, 2001-03, Vol.39 (3), p.126

2001

Link zum Volltext

Verfügbarkeit prüfen

Risk-Benefit Value of Inhaled Glucocorticoids: A Pharmacokinetic/ Pharmacodynamic Perspective

Journal of clinical pharmacology, 2004-01, Vol.44 (1), p.37-47

2004

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics and Concentration-Effect Analysis of Intravenous RGD891, a Platelet GPIIb/IIIa Antagonist, Using Mixed-Effects Modeling (NONMEM)

Journal of clinical pharmacology, 2000-10, Vol.40 (10), p.1129-1140

2000

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of Population Pharmacokinetics and Exposure-Response Relationship With Coadministration of Amlodipine Besylate and Olmesartan Medoxomil

Journal of clinical pharmacology, 2008-07, Vol.48 (7), p.823-836

2008

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Ciclesonide, a Novel Inhaled Steroid, Does Not Affect Hypothalamic-Pituitary-Adrenal Axis Function in Patients With Moderate-to-Severe Persistent Asthma

The Use of Modeling and Simulation to Guide Clinical Development of Olmesartan Medoxomil in Pediatric Subjects

Population pharmacokinetic analysis to identify the possibility of interaction between anti-cancer agents

Population Pharmacokinetics and Pharmacodynamics of Ciclesonide

Randomised, parallel-group, multicentre, multinational phase 2 study comparing edoxaban, an oral factor Xa inhibitor, with warfarin for stroke prevention in patients with atrial fibrillation

Effect of a very late antigen-4 receptor antagonist on allergen-induced airway responses and inflammation in asthma

Modelling and simulation of edoxaban exposure and response relationships in patients with atrial fibrillation

Prospective dose prediction for FXa inhibitor otamixaban (OTAM) using PK/PD simulations accounting for non-dose proportional plasma exposure

Development of a Predictive Pharmacokinetic Model for a Novel Cyclooxygenase-2 Inhibitor

Predictive Population Pharmacokinetic/Pharmacodynamic Model for a Novel COX-2 Inhibitor

Pharmacokinetics, Pharmacodynamics, and Safety of Inhaled Cyclosporin A (ADI628) after Single and Repeated Administration in Healthy Male and Female Subjects and Asthmatic Patients

Usability of a novel digital medicine system in adults with schizophrenia treated with sensor-embedded tablets of aripiprazole

Pharmacokinetics of Methylprednisolone and Prednisolone After Single and Multiple Oral Administration

PK/PD of inhaled corticosteroids: The risk/benefit of inhaled ciclesonide

A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Ebastine 20 mg Once Daily Given with and without Food in the Treatment of Seasonal Allergic Rhinitis

Pharmacokinetic/pharmacodynamic evaluation of deflazacort in comparison to methylprednisolone and prednisolone

Pharmacokinetic-Pharmacodynamic Modeling of the Antilipolytic Effects of an Adenosine Receptor Agonist in Healthy Volunteers

Characterisation of exposure versus response of edoxaban in patients undergoing total hip replacement surgery

High doses of the novel inhaled steroid ciclesonide have no effect on HPA-axis function in patients with moderate-to-severe persistent asthma

Ciclesonide, a novel inhaled steroid, has no effect on hypothalamic-pituitary-adrenal (HPA)-axis function in mild-to-moderate asthmatics

Critical period for a teratogenic VLA-4 antagonist: Developmental effects and comparison of embryo drug concentrations of teratogenic and non-teratogenic VLA-4 antagonists

Effect of age and gender on the pharmacokinetics of ebastine after single and repeated dosing in healthy subjects

Risk-Benefit Value of Inhaled Glucocorticoids: A Pharmacokinetic/ Pharmacodynamic Perspective

Pharmacokinetics and Concentration-Effect Analysis of Intravenous RGD891, a Platelet GPIIb/IIIa Antagonist, Using Mixed-Effects Modeling (NONMEM)

Evaluation of Population Pharmacokinetics and Exposure-Response Relationship With Coadministration of Amlodipine Besylate and Olmesartan Medoxomil

Suchergebnisse filtern